Effect of Flex-a-New on Osteoarthritis of the Knee
Primary Purpose
Osteoarthritis
Status
Unknown status
Phase
Phase 4
Locations
Israel
Study Type
Interventional
Intervention
flex-a-new (food supplement)
Sponsored by
About this trial
This is an interventional treatment trial for Osteoarthritis focused on measuring knee osteoarthritis
Eligibility Criteria
Inclusion Criteria: knee osteoarthritis grade 1 to 3 - Exclusion Criteria: ischemic heart disease with CHF -
Sites / Locations
- Rabin Medical CenterRecruiting
Outcomes
Primary Outcome Measures
KOOS
Secondary Outcome Measures
VAS KSS
Full Information
NCT ID
NCT00294801
First Posted
February 21, 2006
Last Updated
February 21, 2006
Sponsor
Rabin Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT00294801
Brief Title
Effect of Flex-a-New on Osteoarthritis of the Knee
Study Type
Interventional
2. Study Status
Record Verification Date
February 2006
Overall Recruitment Status
Unknown status
Study Start Date
January 2006 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 2007 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Rabin Medical Center
4. Oversight
5. Study Description
Brief Summary
comparative trial of placebo versus flex-a-new (a food supplement) containing glucosamine an chondroitin sulfate for the symptom modification is knee osteoarthritis
Detailed Description
comparative trial of placebo versus flex-a-new (a food supplement) containing glucosamine an chondroitin sulfate for the symptom modification is knee osteoarthritis
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis
Keywords
knee osteoarthritis
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
80 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
flex-a-new (food supplement)
Primary Outcome Measure Information:
Title
KOOS
Secondary Outcome Measure Information:
Title
VAS KSS
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
knee osteoarthritis grade 1 to 3 -
Exclusion Criteria:
ischemic heart disease with CHF -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
dror robinson
Organizational Affiliation
Rabin Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rabin Medical Center
City
Petah Tikwa
ZIP/Postal Code
49372
Country
Israel
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
dror robinson, md
Phone
972-3-9372233
Email
drorr@clalit.org.il
First Name & Middle Initial & Last Name & Degree
dror robinson, md
12. IPD Sharing Statement
Learn more about this trial
Effect of Flex-a-New on Osteoarthritis of the Knee
We'll reach out to this number within 24 hrs